series-a
Stage
1
Investors
About
ExVivo develops a microfluidics-based medical diagnostic tool that enables safe, simple, and non-invasive allergy testing.
Explore ExVivo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.